Zavation acquired Pan Medical U.S. Corp. (PanMed), a manufacturer of products used in kyphoplasty and interventional radiology.
With the acquisition, Zavation gains a full suite of minimally invasive products to add to its portfolio of spinal hardware and biologics covering cervical, thoracolumbar and interbody fusion.
Founded in the UK in 1988, PanMed shifted its focus to the U.S. market and relocated to Florida in 2016. Its product line includes CurvePlus, the only FDA-cleared kyphoplasty system that allows for both the balloon and cement to be passed through a curved needle. According to PanMed, this facilitates precise balloon placement while decreasing procedure time.
Zavation’s current kyphoplasty product is the ZVPlasty system.
Baird served as financial advisor to private equity firm LongueVue Capital, owner of Zavation. Abacus Finance Group, LLC provided senior debt financing to Zavation. Legal counsel was provided by McGuireWoods, LLP.
Sources: Zavation; ORTHOWORLD, Inc.